CaRLO — Cancer Research Library Online

Hits per page

hit 1 - 1 | 1 hit

Select All Export

Unknown

Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target (2018)

E. M. M. Abdelwahab; S. Pal; K. Kvell; V. Sarosi; P. Bai; R. Rue; V. Krymskaya; D. McPhail; A. Porter; J. E. Pongracz

Nature Publishing Group (NPG)

In: Oncogene

add to mindlist on the mindlist

Details

Publication Date: 2018-12-21

Description: Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target, Published online: 20 December 2018; doi:10.1038/s41388-018-0625-1 Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target

Print ISSN: 0950-9232

Topics: Medicine

Published by Nature Publishing Group (NPG)

Signatur	Availability

Others were also interested in ...

PAPER CURRENT

Fulltext

hit 1 - 1 | 1 hit